These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4074431)

  • 1. Clinical effects of oral cilostazol on suppression of platelet function in patients with cerebrovascular disease.
    Yasunaga K; Mase K
    Arzneimittelforschung; 1985; 35(7A):1186-8. PubMed ID: 4074431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiaggregatory effect of oral cilostazol and recovery of platelet aggregability in patients with cerebrovascular disease.
    Yasunaga K; Mase K
    Arzneimittelforschung; 1985; 35(7A):1189-92. PubMed ID: 4074432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cilostazol on platelet aggregation and experimental thrombosis.
    Kimura Y; Tani T; Kanbe T; Watanabe K
    Arzneimittelforschung; 1985; 35(7A):1144-9. PubMed ID: 4074426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cilostazol on platelet function.
    Uehara S; Hirayama A
    Arzneimittelforschung; 1989 Dec; 39(12):1531-4. PubMed ID: 2487508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effect of cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans.
    Yasuda K; Sakuma M; Tanabe T
    Arzneimittelforschung; 1985; 35(7A):1198-200. PubMed ID: 4074434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of the antithrombotic drug cilostazol in chronic arterial occlusion in the extremities.
    Kamiya T; Sakaguchi S
    Arzneimittelforschung; 1985; 35(7A):1201-3. PubMed ID: 4074435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cilostazol, a new antithrombotic drug, on cerebral circulation.
    Kawamura K; Watanabe K; Kimura Y
    Arzneimittelforschung; 1985; 35(7A):1149-54. PubMed ID: 4074427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effect of cilostazol on cerebral blood flow in chronic cerebral infarction.
    Kobayashi S; Yamaguchi S; Katsube T; Kitani M; Okada K; Tsunematsu T
    Arzneimittelforschung; 1985; 35(7A):1193-7. PubMed ID: 4074433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
    Shintani S; Watanabe K; Kawamura K; Mori T; Tani T; Toba Y; Sasabe H; Nakagiri N; Hongoh O; Fujita S
    Arzneimittelforschung; 1985; 35(7A):1163-72. PubMed ID: 3000392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermographic evaluation of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion.
    Ohashi S; Iwatani M; Hyakuna Y; Morioka Y
    Arzneimittelforschung; 1985; 35(7A):1203-8. PubMed ID: 4074436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.
    Shintani S; Toba Y; Suzuki S; Ninomiya S; Umezato M; Hiyama T
    Arzneimittelforschung; 1985; 35(7A):1157-62. PubMed ID: 4074429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The localization of a new antithrombotic agent, cilostazol, in CHO-K1 cells as demonstrated by autoradiography.
    Usuda N; Nagata T; Naka M; Hidaka H
    Arzneimittelforschung; 1985; 35(7A):1141-3. PubMed ID: 4074425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased external carotid artery blood flow in headache patients induced by cilostazol. Preliminary communication.
    Yamashita K; Kobayashi S; Okada K; Tsunematsu T
    Arzneimittelforschung; 1990 May; 40(5):587-8. PubMed ID: 2383301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo. Randomized, double-blind cross-over study.
    Ikeda Y; Kikuchi M; Murakami H; Satoh K; Murata M; Watanabe K; Ando Y
    Arzneimittelforschung; 1987 May; 37(5):563-6. PubMed ID: 2956957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolism of a new antithrombotic and vasodilating agent, cilostazol, in rat, dog and man.
    Akiyama H; Kudo S; Shimizu T
    Arzneimittelforschung; 1985; 35(7A):1133-40. PubMed ID: 4074424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of cilostazol. Safety evaluation at increasing single doses in healthy volunteers.
    Niki T; Mori H
    Arzneimittelforschung; 1985; 35(7A):1173-85. PubMed ID: 4074430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
    Vilahur G; Pena E; Padró T; Badimon L
    Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cilostazol, a new antithrombotic drug, on an experimental model of peripheral circulation insufficiency.
    Kawamura K; Fujita S; Tani T; Kimura Y
    Arzneimittelforschung; 1985; 35(7A):1154-6. PubMed ID: 4074428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physico-chemical properties and stability of cilostazol.
    Shimizu T; Osumi T; Niimi K; Nakagawa K
    Arzneimittelforschung; 1985; 35(7A):1117-23. PubMed ID: 4074422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
    Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
    Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.